Cadre Holdings, Inc. (NYSE:CDRE – Get Free Report) Director Nicolas Sokolow sold 5,000 shares of the stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $33.25, for a total value of $166,250.00. Following the sale, the director now owns 482,620 shares in the company, valued at approximately $16,047,115. This represents a 1.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Nicolas Sokolow also recently made the following trade(s):
- On Monday, November 25th, Nicolas Sokolow sold 1,095 shares of Cadre stock. The shares were sold at an average price of $34.10, for a total value of $37,339.50.
Cadre Trading Down 0.3 %
Cadre stock opened at $33.45 on Friday. Cadre Holdings, Inc. has a 52-week low of $29.18 and a 52-week high of $40.28. The company has a market cap of $1.36 billion, a P/E ratio of 40.30, a P/E/G ratio of 1.98 and a beta of 1.30. The company has a quick ratio of 1.96, a current ratio of 3.01 and a debt-to-equity ratio of 0.65. The business has a 50-day simple moving average of $36.37 and a two-hundred day simple moving average of $34.95.
Cadre Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, November 1st were issued a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 1.05%. The ex-dividend date was Friday, November 1st. Cadre’s dividend payout ratio is presently 42.17%.
Analyst Upgrades and Downgrades
Separately, Roth Mkm decreased their price objective on shares of Cadre from $39.00 to $37.00 and set a “buy” rating for the company in a report on Thursday, November 7th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $39.75.
View Our Latest Analysis on CDRE
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in CDRE. Vanguard Group Inc. raised its stake in Cadre by 21.2% during the 1st quarter. Vanguard Group Inc. now owns 1,180,212 shares of the company’s stock worth $42,724,000 after acquiring an additional 206,564 shares during the period. Advisors Asset Management Inc. purchased a new position in shares of Cadre during the 1st quarter valued at $358,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Cadre by 32.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 460,500 shares of the company’s stock valued at $16,671,000 after buying an additional 113,722 shares in the last quarter. California State Teachers Retirement System boosted its holdings in Cadre by 11.5% in the 1st quarter. California State Teachers Retirement System now owns 22,234 shares of the company’s stock worth $805,000 after buying an additional 2,301 shares during the period. Finally, Zimmer Partners LP purchased a new stake in Cadre in the 1st quarter worth $11,990,000. 43.95% of the stock is owned by hedge funds and other institutional investors.
Cadre Company Profile
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
Read More
- Five stocks we like better than Cadre
- The Role Economic Reports Play in a Successful Investment Strategy
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is Insider Trading? What You Can Learn from Insider Trading
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Are Dividend Champions? How to Invest in the Champions
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.